Atrial fibrillation, commonly called AFib, is the most widespread heart rhythm disorder in the world. It affects more than 59 million people globally, and that number continues to climb as populations age. In the United States alone, experts project AFib cases could exceed 12 million by 2030. Despite how common it is, many people live with AFib for months or even years without realizing it.
AFib matters because it carries serious risks. It increases the chance of stroke by up to five times, contributes to heart failure, and significantly diminishes everyday quality of life. Symptoms like fatigue, shortness of breath, and an irregular heartbeat can make even simple activities feel exhausting and frightening.
This article explains what AFib is, how doctors recognize and diagnose it, and what treatment options are available — written in plain language for patients, families, and anyone seeking trustworthy, practical heart health information.
Understanding Atrial Fibrillation: What Is Actually Happening in the Heart
To understand AFib, it helps to first picture how a healthy heart beats. Normally, your heart follows a precise electrical routine called normal sinus rhythm. A tiny cluster of cells in the upper right chamber — called the sinoatrial (SA) node — acts like a natural pacemaker. It sends a steady electrical signal that travels through both upper chambers (the atria), then moves down to the lower chambers (the ventricles), causing them to squeeze in a smooth, coordinated pattern. This organized sequence pumps blood efficiently throughout your body, typically at a rate of 60 to 100 beats per minute.
In AFib, this orderly process breaks down completely. Instead of one clean signal from the SA node, the atria receive hundreds of chaotic, disorganized electrical impulses every minute. As a result, the atria quiver rather than contract properly — a movement cardiologists sometimes describe as resembling a “bag of worms.” This loss of coordinated contraction means blood is no longer pumped smoothly out of the atria and into the ventricles.
When blood lingers in the atria without being fully expelled, it can pool — particularly in a small pouch called the left atrial appendage. Stagnant blood has a dangerous tendency to clot, and if a clot breaks free, it can travel to the brain and cause a stroke.
AFib is distinct from other arrhythmias. For example, atrial flutter involves a fast but more organized circuit, while ventricular fibrillation is a life-threatening emergency involving the lower chambers.
Normal Sinus Rhythm vs. Atrial Fibrillation
The following table highlights the key differences between a normal sinus rhythm and atrial fibrillation across several important features.
| Feature | Normal Sinus Rhythm | Atrial Fibrillation |
|---|---|---|
| Electrical Signal Origin | Sinoatrial (SA) node — one organized source | Multiple chaotic, disorganized sites in the atria |
| Heart Rate | 60–100 beats per minute (regular) | Often 100–175 beats per minute (irregular) |
| Atrial Contraction | Coordinated, effective squeeze | Quivering, uncoordinated — no true contraction |
| Blood Flow Efficiency | Optimal — blood moves smoothly to ventricles | Reduced — blood pools, especially in left atrial appendage |
| Stroke Risk | Low (baseline risk) | Significantly elevated — up to 5 times higher than normal |
These distinctions underscore why AFib disrupts normal heart function and why it carries such significant health risks compared to a healthy rhythm.
Types and Patterns of AFib
Not all atrial fibrillation is the same. Cardiologists classify AFib into distinct types based on how long episodes last, how often they occur, and whether the heart can return to a normal rhythm on its own. Understanding which type a patient has is essential for choosing the right treatment approach.
Based on duration and recurrence, AFib can be classified into several distinct types:
- Paroxysmal AFib comes and goes on its own, typically resolving within 7 days without medical intervention. Many patients experience brief episodes lasting minutes to hours before the heart naturally resets itself.
- Persistent AFib lasts longer than 7 days and does not stop without treatment. A doctor must use medication or a procedure called cardioversion to restore a normal rhythm.
- Long-standing persistent AFib describes a continuous episode lasting more than 12 months. At this stage, the heart has been in irregular rhythm for so long that restoring normal function becomes significantly more challenging.
- Permanent AFib is diagnosed when both the patient and doctor mutually agree that further attempts to restore normal rhythm are no longer the primary goal. Instead, the focus shifts entirely to controlling heart rate and preventing complications like stroke.
Each classification directly influences the treatment strategy. Early-stage paroxysmal AFib may only require lifestyle changes and medication, while long-standing cases often need more aggressive interventions.
There are also other terms used to describe AFib in specific patient groups. Lone AFib refers to AFib occurring in younger, otherwise healthy individuals without underlying heart disease or major risk factors. Silent AFib is particularly concerning — these are episodes with no noticeable symptoms, often discovered accidentally during routine checkups, yet they still carry serious stroke risk.
AFib Types at a Glance
The table below summarizes the four main AFib classifications, their defining characteristics, and the typical next steps in management.
| Type | Duration | Key Characteristic | Typical Next Step |
|---|---|---|---|
| Paroxysmal | Under 7 days | Self-terminating | Monitor; medications if frequent |
| Persistent | Over 7 days | Requires intervention | Cardioversion or medication |
| Long-standing Persistent | Over 12 months | Continuous irregular rhythm | Advanced procedures considered |
| Permanent | Ongoing | Rhythm control abandoned | Rate control and stroke prevention |
Recognizing which category a patient falls into allows cardiologists to tailor the most appropriate and effective treatment plan.
Recognizing AFib: Symptoms and Risk Factors
AFib affects people differently, which is one reason it can be difficult to recognize. The most common symptoms include heart palpitations (a fluttering or racing sensation in the chest), an irregular heartbeat, shortness of breath, unusual fatigue, dizziness, and mild chest discomfort. Some people feel these symptoms intensely, while others barely notice them — or feel nothing at all. This variation depends on factors like age, overall heart health, and how long AFib episodes last.
Certain symptoms demand immediate attention. If you or someone nearby experiences sudden chest pain, fainting, difficulty speaking, facial drooping, arm weakness, or vision changes, call 911 immediately, as these may signal a stroke or serious cardiac emergency.
Call 911 or go to the emergency room if you experience any of the following warning signs:
- Sudden, severe chest pain or pressure
- Fainting or loss of consciousness
- Sudden weakness or numbness in the face, arm, or leg
- Difficulty speaking or understanding speech
- Sudden vision changes in one or both eyes
- Severe shortness of breath at rest
- Rapid, uncontrolled heartbeat lasting more than 30 minutes
Prompt action in response to these symptoms can be life-saving and should never be delayed. Beyond recognising symptoms and knowing when to seek emergency care, it is also important to understand the factors that can increase the likelihood of developing AFib.
Some AFib risk factors cannot be changed. Risk rises sharply after age 65, and family history or genetic predisposition also plays a role. However, many risk factors are modifiable. These include high blood pressure, obesity, sleep apnea, excessive alcohol consumption, hyperthyroidism, diabetes, and smoking. Existing heart conditions — such as heart failure, coronary artery disease, and valvular disease — further elevate risk. Notably, lifestyle-related AFib is increasingly appearing in younger adults, making healthy habits more important than ever.
How Cardiologists Diagnose AFib
Diagnosing atrial fibrillation requires more than a single test. Cardiologists use a combination of patient history, physical exams, and specialized tools to confirm AFib, identify its type, and assess its risks.
Initial Evaluation
The diagnostic process begins with a thorough conversation. Your cardiologist will ask about your symptoms — palpitations, fatigue, shortness of breath, dizziness, or chest discomfort — and how often they occur. They will also review your medical history, including high blood pressure, diabetes, thyroid disease, and prior heart conditions, all of which raise AFib risk.
During the physical exam, the doctor checks your pulse for an irregular rhythm, which is a hallmark sign of AFib. They also listen carefully to your heart sounds using a stethoscope, looking for abnormal beats or signs of underlying heart disease.
Electrocardiogram (ECG/EKG)
The ECG is the primary tool for diagnosing AFib. It records the heart’s electrical activity through small electrodes placed on the skin. In AFib, cardiologists look for two specific abnormalities: the absence of distinct P waves (the signal that normally triggers each heartbeat) and an irregularly irregular R-R interval, meaning the spaces between heartbeats vary unpredictably.
However, a standard ECG only captures a brief snapshot — typically 10 to 30 seconds. If your AFib comes and goes, it may not appear during that short window.
Ambulatory Heart Monitoring
When an ECG misses the arrhythmia, doctors turn to longer-term monitoring options:
- Holter monitor: A portable device worn for 24–48 hours that records every heartbeat continuously.
- Extended event monitors: Worn for up to 30 days, these are ideal for infrequent or intermittent AFib episodes.
- Implantable loop recorder (ILR): A small device inserted under the skin that monitors heart rhythm for up to three years. It is particularly useful for patients who had a stroke of unknown cause (cryptogenic stroke) or whose AFib remains difficult to detect.
- Wearable technology: Smartwatches like the Apple Watch can detect irregular rhythms and even generate a single-lead ECG. While helpful for alerting patients, these devices are not a substitute for clinical-grade monitoring and require physician confirmation.
Each monitoring option serves a different purpose, and the right choice depends on how frequently and predictably a patient’s AFib episodes occur.
Echocardiography
An echocardiogram uses sound waves to create images of the heart’s structure and function.
- Transthoracic echocardiogram (TTE): Performed by placing a probe on the chest, this test evaluates heart size, valve function, and pumping strength.
- Transesophageal echocardiogram (TEE): A probe is guided down the throat to get a closer view of the heart. This is especially important before cardioversion (restoring normal rhythm), as it detects dangerous blood clots in the left atrial appendage (LAA) that could cause a stroke if dislodged.
Together, these imaging tools give cardiologists a comprehensive picture of the heart’s anatomy and help guide safe treatment decisions.
Additional Diagnostic Tests
Beyond cardiac monitoring, cardiologists order supporting tests to uncover underlying causes:
- Blood tests: Thyroid function tests identify hyperthyroidism, a known AFib trigger. A complete metabolic panel checks kidney and liver health, while a complete blood count (CBC) screens for anemia or infection.
- Chest X-ray: This helps identify enlarged heart chambers, fluid in the lungs, or pulmonary conditions that may contribute to AFib.
- Sleep study: Because obstructive sleep apnea is strongly linked to AFib, a sleep study may be recommended when symptoms like loud snoring or daytime fatigue are present.
These additional tests help ensure that any contributing conditions are identified and addressed as part of a complete AFib management plan.
Typical Diagnostic Workup Sequence a Cardiologist Follows
The following steps outline the standard sequence cardiologists use to diagnose and classify AFib in a new patient.
- Step 1 — Symptom and History Review: Discuss symptoms, risk factors, and relevant medical history.
- Step 2 — Physical Examination: Check pulse irregularity and listen to heart sounds.
- Step 3 — 12-Lead ECG: Perform immediate electrical recording to detect AFib patterns.
- Step 4 — Ambulatory Monitoring: Prescribe a Holter monitor or event recorder if ECG is inconclusive.
- Step 5 — Echocardiogram: Evaluate heart structure, function, and clot risk.
- Step 6 — Blood Tests and Chest X-ray: Rule out thyroid disease, anemia, and structural causes.
- Step 7 — Confirmed Diagnosis and Risk Stratification: Classify AFib type and calculate stroke risk using the CHA₂DS₂-VASc score.
Following this structured sequence ensures that no critical diagnostic step is overlooked and that the AFib diagnosis is both accurate and complete.
Stroke Risk Stratification
One of the most critical steps after diagnosing AFib is assessing stroke risk. Because AFib allows blood to pool in the left atrium, clots can form and travel to the brain. Cardiologists use the CHA₂DS₂-VASc scoring system to determine who needs blood-thinning medication (anticoagulation therapy).
Each letter in the acronym stands for a risk factor, and points are assigned based on how many a patient has. A higher score means greater stroke risk and a stronger recommendation for anticoagulation.
The table below lists each risk factor included in the CHA₂DS₂-VASc scoring system along with the number of points assigned to each.
| Risk Factor | Assigned Points |
|---|---|
| C — Congestive heart failure | 1 |
| H — Hypertension (high blood pressure) | 1 |
| A₂ — Age 75 years or older | 2 |
| D — Diabetes mellitus | 1 |
| S₂ — Prior stroke, TIA, or blood clot | 2 |
| V — Vascular disease (prior heart attack or artery disease) | 1 |
| A — Age 65–74 years | 1 |
| Sc — Sex category (female sex) | 1 |
| Maximum possible score | 9 |
Score Interpretation Guide:
- Score 0: Low risk — anticoagulation generally not recommended.
- Score 1: Low-to-moderate risk — treatment decision made individually based on clinical judgment.
- Score ≥ 2: Elevated risk — anticoagulation therapy is strongly recommended to prevent stroke.
This scoring system ensures that treatment decisions are personalized, balancing the benefit of stroke prevention against the potential bleeding risks of blood-thinning medications.
Treatment Goals and the Two Core Strategies
When a cardiologist confirms an AFib diagnosis, the next critical step is deciding how to treat it. Treatment generally focuses on two primary goals: rate control and rhythm control.
Rate control means slowing the heart’s ventricular rate to a safer, more comfortable pace — typically below 110 beats per minute at rest. This reduces symptoms like fatigue and shortness of breath and protects the heart muscle from long-term damage caused by persistently fast beating.
Rhythm control takes a different approach, aiming to restore the heart’s normal sinus rhythm and keep it there using medications or procedures.
Cardiologists weigh several factors when choosing between these strategies, including the patient’s age, how severe their symptoms are, whether AFib is occasional or persistent, and what other health conditions exist.
Importantly, stroke prevention runs alongside both strategies — not replacing either one. Because AFib significantly raises stroke risk regardless of heart rate, blood-thinning medications are often prescribed independently of rate or rhythm decisions.
There is no single, universal treatment plan for AFib. Every patient’s situation is unique, and cardiologists carefully tailor treatment to deliver the safest, most effective outcome for that individual.
Stroke Prevention: Anticoagulation Therapy
For many people with AFib, stroke prevention is the single most important treatment goal. Because the heart’s upper chambers quiver instead of pumping smoothly, blood can pool and form clots. If a clot travels to the brain, it causes a stroke — and AFib is responsible for approximately 1 in 7 strokes. These strokes tend to be severe and disabling, making anticoagulation therapy (blood thinners) often the most critical intervention a cardiologist recommends.
Two main classes of anticoagulants are used:
- Warfarin (a vitamin K antagonist) works by blocking clotting factors dependent on vitamin K. It requires regular INR blood test monitoring and is sensitive to dietary changes — foods rich in vitamin K, like leafy greens, can interfere with its effectiveness.
- Direct Oral Anticoagulants (DOACs) — including apixaban, rivaroxaban, dabigatran, and edoxaban — are newer options that don’t require routine INR monitoring and have fewer dietary interactions, making them more convenient for most patients.
Doctors use the CHA₂DS₂-VASc score to decide who needs anticoagulation, assigning points for risk factors like age, heart failure, and diabetes. The HAS-BLED score helps evaluate bleeding risk before prescribing.
Some patients — those with active bleeding disorders or high fall risk — may not safely tolerate anticoagulants. For them, procedures like left atrial appendage closure (Watchman device) offer an alternative stroke prevention strategy.
Warfarin vs. DOACs
The table below compares warfarin and direct oral anticoagulants (DOACs) across several clinically important features to help illustrate when each may be preferred.
| Feature | Warfarin | DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) |
|---|---|---|
| Monitoring Required | Yes — regular INR blood tests needed | No routine monitoring required |
| Dietary Restrictions | Yes — vitamin K-rich foods affect levels | Minimal to none |
| Drug Interactions | Many — antibiotics, NSAIDs, and others | Fewer, but some still exist |
| Reversal Agents Available | Yes — vitamin K, fresh frozen plasma | Yes — idarucizumab (dabigatran); andexanet alfa (apixaban, rivaroxaban) |
| Typical Use Cases | Patients with mechanical heart valves; those unable to afford DOACs | Most AFib patients without kidney failure or specific contraindications |
Choosing the right anticoagulant depends on each patient’s individual health profile, lifestyle, and financial considerations, and should always be made in close consultation with a cardiologist.
Rate Control: Slowing the Heart Without Restoring Rhythm
For some patients, particularly older adults or those with long-standing AFib, restoring a normal rhythm may not be the primary goal. Instead, doctors focus on rate control — slowing the heart rate to a safer, more comfortable level, generally below 110 beats per minute at rest, according to current cardiology guidelines.
Several medications accomplish this effectively:
- Beta-blockers (metoprolol, atenolol) — reduce heart rate by blocking adrenaline’s effects on the heart
- Calcium channel blockers (diltiazem, verapamil) — relax the heart’s electrical conduction pathways
- Digoxin — plays a limited role, mainly helpful in patients with heart failure or those who are less physically active
One critical point every patient must understand: rate control does not eliminate stroke risk. Even when the heart rate feels normal and symptoms improve, the irregular rhythm may persist silently, allowing dangerous blood clots to form. Therefore, anticoagulation therapy — blood thinners — remains equally important alongside rate control. Managing both aspects together gives patients the best protection against AFib’s most serious complications.
Rhythm Control: Restoring Normal Sinus Rhythm
When rate control alone is not enough, doctors focus on rhythm control — actively restoring the heart’s normal, steady beat, called sinus rhythm.
Cardioversion
Electrical cardioversion (DC cardioversion) delivers a carefully timed electric shock to the heart through pads placed on the chest. The patient receives light sedation beforehand, so there is no pain or awareness during the procedure. It works quickly, restoring normal rhythm in roughly 70–90% of cases, though AFib can return over time without additional treatment.
Pharmacological cardioversion uses antiarrhythmic medications — such as ibutilide or flecainide — to chemically reset the heart’s rhythm. This approach suits carefully selected patients whose AFib began recently and who have no serious structural heart disease.
Antiarrhythmic Drug Therapy
After cardioversion, the goal shifts to keeping the heart in normal rhythm. Doctors commonly prescribe agents such as flecainide, propafenone, sotalol, dofetilide, or amiodarone. Drug selection depends heavily on a patient’s underlying heart condition — for example, amiodarone is often chosen for patients with heart failure, while flecainide is reserved for those with structurally normal hearts. Regular monitoring is essential because these medications can occasionally trigger new arrhythmias, a risk called a proarrhythmic effect.
Catheter Ablation
Catheter ablation is a minimally invasive procedure where a thin, flexible tube targets and destroys the abnormal electrical tissue causing AFib — most often through pulmonary vein isolation (PVI). Ideal candidates include symptomatic patients who have not responded to medications or who prefer a non-drug approach. Success rates range from 60–80%, with some patients requiring a repeat procedure. Encouragingly, recent evidence supports using ablation earlier in selected patients to improve long-term outcomes.
Cardioversion vs. Catheter Ablation
The table below compares electrical cardioversion and catheter ablation to help clarify when each approach is most appropriate for AFib patients.
| Feature | Electrical Cardioversion | Catheter Ablation |
|---|---|---|
| Purpose | Quickly restore normal rhythm | Long-term rhythm control |
| Procedure Type | Non-invasive; external shock under sedation | Minimally invasive; catheter inserted through blood vessels |
| Duration | Minutes | 2–4 hours |
| Typical Outcomes | Fast restoration; AFib may recur without medication | Durable rhythm control; recurrence possible |
| Best For | Acute AFib episodes; rapid stabilization | Symptomatic AFib; medication failure |
| Recovery | Same-day discharge; minimal downtime | 1–3 days rest; activity restrictions for one week |
Both approaches aim to give patients a better quality of life by keeping the heart beating as it should.
Surgical and Device-Based Interventions
When medications and catheter-based procedures fall short, surgeons and cardiologists may turn to more advanced interventions to manage AFib effectively.
- Surgical Ablation (Maze Procedure) This open-heart surgery creates a precise pattern of scar tissue inside the heart’s upper chambers, blocking the chaotic electrical signals responsible for AFib. It is typically performed on patients already undergoing cardiac surgery for other reasons, such as valve repair or bypass grafting.
- Left Atrial Appendage Closure (LAAC) More than 90% of AFib-related blood clots form inside a small pouch called the left atrial appendage (LAA). Sealing it off dramatically reduces stroke risk. The Watchman device — a small, umbrella-like implant — is inserted through a catheter without open surgery. FDA-approved and widely used, it offers a viable alternative for patients who cannot safely take long-term blood thinners. Candidates are carefully selected based on bleeding history, kidney function, and overall health.
- AV Node Ablation with Pacemaker Implantation Considered a last resort for rate control, this procedure intentionally disrupts the heart’s electrical bridge between upper and lower chambers. Because the heart can no longer regulate its own rhythm naturally, a permanent pacemaker is implanted to maintain a steady, reliable heartbeat.
These advanced interventions offer additional options for patients whose AFib remains difficult to manage with medications or catheter-based treatments. The choice of procedure depends on the patient’s specific condition, treatment goals, and overall health.
Lifestyle Modifications and AFib Management
Research increasingly confirms that lifestyle choices directly influence how often AFib episodes occur and how severe they become. These changes won’t replace medication or procedures, but they meaningfully support your overall treatment plan.
Weight loss is particularly powerful. Studies show that obese patients who lose even 10% of their body weight experience significantly fewer AFib episodes. Treating obstructive sleep apnea — a condition that stresses the heart overnight — also reduces AFib burden considerably.
Alcohol has a dose-dependent relationship with AFib, meaning more drinks equal greater risk. Even moderate reduction helps. Blood pressure control remains a constant priority, since hypertension strains the heart’s electrical system. Regular moderate-intensity exercise — like brisk walking or cycling — strengthens cardiovascular health, though extreme endurance sports (marathons, triathlons) can paradoxically increase AFib risk. Smoking cessation and limiting stimulants like excessive caffeine also support heart rhythm stability, although caffeine’s role is more nuanced than once believed.
Lifestyle Modifications That Support AFib Management
The following actionable steps are recommended for discussion with your care team as part of a comprehensive AFib management plan.
- Achieve and maintain a healthy weight
- Get screened and treated for sleep apnea
- Reduce or eliminate alcohol consumption
- Control blood pressure through diet, medication, and stress reduction
- Exercise moderately and consistently
- Quit smoking completely
- Limit excessive caffeine intake
Incorporating these lifestyle changes alongside medical treatment gives patients the best chance of reducing AFib episodes and improving long-term heart health.
Living With AFib: Monitoring, Follow-Up, and Patient Empowerment
Atrial fibrillation is not a condition you treat once and forget. It is a chronic, lifelong condition that requires ongoing attention, regular medical follow-up, and active daily self-management. Understanding this early helps patients build realistic expectations and healthier habits.
- Regular Cardiology Follow-Up: Routine visits allow your cardiologist to adjust medications, review heart rhythm trends, and catch early signs of disease progression before they become serious complications.
- Home Monitoring Essentials: Daily self-monitoring plays a powerful supporting role. Patients should regularly check their pulse for irregularities, maintain blood pressure logs, and consider wearable cardiac monitors or smartwatch ECG features that can detect rhythm changes between appointments.
- Recognizing Warning Signs: Report any new or worsening symptoms — increased fatigue, chest discomfort, shortness of breath, or dizziness — to your physician promptly, as these may signal a medication adjustment or progression of AFib.
- Medication Adherence: Anticoagulants are particularly critical. Missing doses significantly raises stroke risk, so establishing a consistent daily routine is essential.
- Lifestyle Reassurance: Most AFib patients can drive, travel, exercise moderately, and maintain sexual activity with physician guidance and appropriate precautions.
- Mental Health Matters: Anxiety and depression are significantly more common among AFib patients. Acknowledging these emotional challenges and seeking support — through counseling, support groups, or medication — is a legitimate and important part of comprehensive AFib care.
- Shared Decision-Making: Patients who understand their options and actively participate in treatment planning consistently experience better outcomes and greater peace of mind.
Consistent follow-up, self-monitoring, medication adherence, attention to symptoms and lifestyle, and shared decision-making can support ongoing AFib management and overall well-being.
Questions to Ask Your Cardiologist About AFib
The following questions are designed to help patients have more informed and productive conversations with their cardiologist at each visit.
| Question | |
|---|---|
| 1 | Medications: “Which anticoagulant is right for me, and what happens if I miss a dose?” |
| 2 | Procedures: “Am I a candidate for cardioversion or catheter ablation, and what are the risks?” |
| 3 | Lifestyle: “What types of exercise are safe for me, and are there activities I should avoid?” |
| 4 | Monitoring: “Should I use a wearable heart monitor or smartwatch ECG between visits?” |
| 5 | Stroke Risk: “What is my current CHA₂DS₂-VASc score, and does it change my treatment plan?” |
| 6 | Follow-Up: “How often should I schedule cardiology visits, and when should I call immediately?” |
| 7 | Mental Health: “Are anxiety or mood changes related to my AFib, and is there support available?” |
| 8 | Future Planning: “If my symptoms worsen, what are the next steps in my treatment options?” |
Bringing these questions to your next appointment can help ensure that all aspects of your AFib care — medical, lifestyle, and emotional — are fully addressed.
Conclusion
AFib is one of the most common heart rhythm disorders, but with the right diagnosis and personalized treatment, it is absolutely manageable. Cardiologists use a clear diagnostic pathway — from ECG and Holter monitoring to risk stratification tools — to identify AFib accurately. Treatment combines rate or rhythm control, stroke prevention medications, lifestyle changes, and consistent long-term follow-up. Left undiagnosed or untreated, AFib significantly raises the risk of stroke and heart failure. If you or a loved one experiences palpitations, fatigue, or dizziness, do not wait — consult a cardiologist promptly. Early action can protect your heart and your future.